Endocrinology
Partner With Us
Advertisement
Conexiant chevron_right Endocrinology chevron_right Is GLP 1RA Use Tied to Short Term Thyroid Cancer Risk
From the Journals

Is GLP-1RA Use Tied to Short-Term Thyroid Cancer Risk?

Study authors attributed the increased cancer risk to greater medical scrutiny rather than a biological effect.

Conexiant
article Full Article subject Summary summarize Notecard
  1. GLP-1 receptor agonists (GLP-1RA) are associated with a higher risk of thyroid cancer diagnosis within the first year of treatment among patients with type 2 diabetes.
  2. Study authors emphasized the need for continued post-market surveillance of these medications.
  3. Enhanced early detection of thyroid cancer is likely responsible for increased risk. 
  4. No established causal link between GLP-1RA treatment and thyroid cancer. 

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.